about
Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese womenNon-invasive quantification of white and brown adipose tissues and liver fat content by computed tomography in miceHigher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States.Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice.Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritisDisruption of protein kinase A in mice enhances healthy aging.Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional studyQuantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopyHepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance.Tissue-specific insulin signaling in the regulation of metabolism and aging.Gastric bypass promotes more lipid mobilization than a similar weight loss induced by low-calorie diet.Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice.Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice.Resistance to diet-induced obesity in mice with synthetic glyoxylate shuntThe effect of aerobic exercise on intrahepatocellular and intramyocellular lipids in healthy subjectsPhysical Activity is Related to Fatty Liver Marker in Obese Youth, Independently of Central Obesity or Cardiorespiratory Fitness.Study of beta-cell function (by HOMA model) in metabolic syndrome.Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RTA metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolismObesity-associated improvements in metabolic profile through expansion of adipose tissue.Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.Is insulin resistance the cause of the metabolic syndrome?Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance.Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy.Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders.Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.Ethnic difference in liver fat content: a cross-sectional observation among Japanese American in Hawaii, Japanese in Japan, and non-Hispanic whites in United StatesComputed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population.Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart diseaseNon-alcoholic fatty liver disease and the metabolic syndrome: an update.Olive oil consumption and non-alcoholic fatty liver diseaseRetinol-binding protein-4 in experimental and clinical metabolic disease.Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction.Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and whole-body lipolysis in healthy young male offspring of patients with type 2 diabetes.Farnesoid X receptor-Acting through bile acids to treat metabolic disorders.Lipotoxicity and cardiac dysfunction in mammals and Drosophila.What we have learnt about PIKE from the knockout mice.
P2860
Q24322032-D18660DD-8CB0-4D85-B9F4-13B9CDB0939EQ28483774-AB6F8FD9-77E5-418A-B8A0-C55B850AB781Q30435348-9550EF3E-BF3B-45A1-AAF2-14690111132EQ30586373-01D4D28B-DD7E-47E6-A3BB-1BF8B45145A2Q33304235-4A63F68E-E810-457B-A4F9-368525A53BF9Q33470238-F9F010E9-DA4D-49B2-A6FC-B270C1604FD4Q33596518-801DCA88-13CE-4761-AE4C-DE88DA04A0E5Q33755379-1D0B24EB-2F2B-4F60-A47E-B660622802C8Q33797528-8BC9EF90-3F97-40F5-8D89-31BA9D6B98ABQ33840644-161B0DCE-C434-4747-94D6-D832662181CEQ34076176-0A186308-257D-42C5-A501-95942B0A0344Q34442926-8B425F71-5FDC-4DDC-A5D9-302B5E4E227BQ34659350-0BD4210C-FCB8-41EC-A859-BE313EACC9CAQ34696866-2D3571F8-7500-4901-86D7-0AF9AECEF498Q34778767-9669A566-B9A4-411B-8638-679CA685F599Q34963080-9D63CD81-032B-4966-B386-851500F49607Q35014575-03D7F295-C143-418A-8AAA-C746C43181F8Q35153078-41216846-AB57-4C03-8A19-FD89B59EECA3Q35543638-6CE1028B-9CD2-4936-A175-589771DA6400Q35776935-52551C13-A89B-456A-B4F1-BC927B94B848Q35945161-FCFDABC6-76D1-46A0-9948-269EE9D8852DQ36084615-3CCD3501-6611-4EED-AA35-5CDC067C4F17Q36298345-6507AA38-EB54-44CC-9316-D7F64FF0F93BQ36383033-B9E3DBA9-E4AD-4F11-BBCD-136353E29CF5Q36487060-58D4B1C8-42E6-45E4-8DF5-FED2203BD383Q36500772-BEB45E48-C306-491D-B79B-F9271FFD84CDQ36650350-16DE49DF-F33D-4FF5-9035-17815A59073FQ36842541-F28C371E-B598-4C49-97FC-A24905DD185DQ36879081-4033F9EC-18FD-4241-988F-2ECD1872CF83Q36997051-0F764B60-3029-483E-BC83-B6C672CCBCEDQ37002532-354A9945-3620-4B29-821B-8E1BF2C9388AQ37054351-0DFD3959-5BB3-476C-9EAF-B40374893D16Q37161600-6C2415ED-3BBE-443A-83EC-0FC3E9D6F0DFQ37206162-E5836C4E-3DA4-4240-B3E7-2A6487E40701Q37316874-340D9CC0-96E3-4202-88DB-15EC1BF79115Q37334591-0562A01D-37FC-4B1E-B572-3A5F8377D379Q37429184-ED19B277-39E1-47F9-9F1F-B059BC3424F8Q37508029-4B976301-3055-426D-8C19-7FBAD44829B5Q37919531-93C3AE05-3865-496B-90A4-5CEF623CF2A3Q37946372-C8BBA89E-60BF-47A0-A2C9-DA1DC015BE5A
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Fat in the liver and insulin resistance.
@ast
Fat in the liver and insulin resistance.
@en
type
label
Fat in the liver and insulin resistance.
@ast
Fat in the liver and insulin resistance.
@en
prefLabel
Fat in the liver and insulin resistance.
@ast
Fat in the liver and insulin resistance.
@en
P2860
P1433
P1476
Fat in the liver and insulin resistance.
@en
P2860
P304
P356
10.1080/07853890510037383
P407
P577
2005-01-01T00:00:00Z